Tacrolimus
Top View
- Autoimmune Progesterone Dermatitis: a Complex 6
- 210115Orig1s000
- The Drug-Drug Interaction Potential of Antiviral Agents for the Treatment of Chronic Hepatitis C Infection
- Hazardous Drug List Gown, Eye and Face Protection in Low (Yellow) - Handle at All Times with Gloves and Appropriate Addition to Any Necessary Engineering Controls
- Pharmacological Drugs Inducing Ototoxicity, Vestibular Symptoms and Tinnitus: a Reasoned and Updated Guide
- Apple Health Medicaid: Fee-For-Service Preferred Drug List
- Australian Public Assessment Report for Tacrolimus
- Korlym (Mifepristone)
- Treatment on Meiotic Chromosomes in Testes, Epididymal Spermatozoa and Fertility in Swiss Albino Male Mice
- Influence of Mycophenolic Acid and Tacrolimus on Homocysteine
- Posttransplantation Tuberculosis Management in Terms of Immunosuppressant Cost
- Mifepristone (Korlym) Reference Number: ERX.SPA.15 Effective Date: 07.01.16 Last Review Date: 02.21 Line of Business: Commercial, Medicaid Revision Log
- Pharmacokinetic Drug–Drug Interaction Study Between Clindamycin and Cyclosporin in Rabbits
- Drug Safety Update
- Clinicaltrials.Gov Identifier: NCT02099864 Oregon Health & Science University OHSU Knight Cancer Institute OHSU Eirb Protocol #: 10241
- NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2014
- Protopic (Tacrolimus) Medication Guide
- Medication Guidelines for Solid Organ Transplants